Evidence map›Paper›PMID 35891730›Full record

ArticleArchives of Razi Institute2022

Effects of

S Hasan Kadhum Al-Huchaimi, G Hameed Neamah Al-Kefaei, B Ahmed Alameedy

Open access · greenAbstract read
In one paragraph

Article in Archives of Razi Institute, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Differentiation and regulation of CD4Cellular and molecular life sciences : CMLS · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

S Hasan Kadhum Al-HuchaimiDepartment of Medical Laboratory Techniques, Imam Ja'afar Al-Sadiq University, Al-Najaf, Iraq.
G Hameed Neamah Al-KefaeiDepartment of Medical Laboratory Techniques, Imam Ja'afar Al-Sadiq University, Al-Najaf, Iraq.
B Ahmed AlameedyDepartment of Medical Laboratory Techniques, Imam Ja'afar Al-Sadiq University, Al-Najaf, Iraq.
Imam Sadiq University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is a psychiatric neurological infection of the focal sensory system and is accepted as a multifactorial disease. Chronic Toxoplasmosis is sometimes associated with the proliferation of bradyzoites in the nervous system. The measurement of interleukin-5 (IL-5) as an inflammatory mediator in patients with PD and Toxoplasmosis infection may be helpful in determining the correlation between these diseases. In the present study, 80 examples were collected, including 35 patients diagnosed with idiopathic PD and 45 samples from healthy people from Najaf, Babylon, and Baghdad provinces, Iraq. After measuring the immunoglobulin G (IgG) antibody of

Indexed as

Interleukin-5Parkinson DiseaseToxoplasmosisAntibodies, ProtozoanHumansImmunoglobulin GToxoplasmaAntibodies, ProtozoanImmunoglobulin GInterleukin-5Interleukin-5Parkinson's diseaseToxoplasma gondii

Identifiers

PMID35891730
PMCPMC9288616
OpenAlexW4288212878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.